Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Andrea Gallamini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research and Clinical Innovation, Antoine Lacassagne Cancer Centre, Nice, France. Hauptthemen laut MEDLINE: Hodgkin Disease, Neoplasm Staging, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Twenty years after the conceptual revolution that occurred in the millennium turnaround upon the introduction of PET/CT in lymphoma staging, restaging, and prognostication, a number of new parameters for PET reading have been proposed: (1) the shift from a qualitative to a semi‐quantitative reading for PET reporting, (2) an international consensus on these novel interpretation keys, (3) a standardized and agreed procedure to measure the total metabolic tumour volume (TMTV), and (4) the proposition of new indexes to portray the tumour spread: (D‐Max and Total Lesion Surface –TLS). These proved to be very powerful prognosticators, able to revolutionize the traditional Ann Arbor four‐stage lymphoma staging. During the 17° Lugano meeting on lymphoma, one main question was asked to experts attending a closed workshop dedicated to new metrics for lymphoma diagnosis, staging, restaging, and prognostication: “Should the traditional 4‐stage anatomic staging system be simplified to a more clinically relevant 2‐stage system (e.g., limited vs. extensive disease)?” Early‐stage HL is an example of how these new metrics could fit with this proposal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research and Clinical Innovation, Antoine Lacassagne Cancer Centre, Nice, France.
- Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Oncology, University of Milan, Milan, Italy.
- Institute of Oncology Research, Bellinzona, Switzerland.
- Department of Haematology, Centre Henri Becquerel, Rouen, France.
- Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Andrea Gallamini
Zitieren
APA
Gallamini, A., Filippi, A., Camus, V., & Vassilakopoulos, T. P. (2024). Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.19657
Vancouver
Gallamini A, Filippi A, Camus V, Vassilakopoulos TP. Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma. British Journal of Haematology. 2024. doi:10.1111/bjh.19657
BibTeX
@article{Gallamini2024,
author = {Gallamini, Andrea and Filippi, Andrea and Camus, Vincent and Vassilakopoulos, Theodoros P},
title = {Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19657}
}
EUVIMED